Metraipolis › archive › dc_b167b9bb88ff

Predictive value of peripheral blood immune markers for castration-resistant prostate cancer development after endocrine therapy — Europe PMC PMID:41704610

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41704610
DOI
10.3389/fonc.2026.1696687
License (as archived)
solo-consultazione
Archived
2026-11-06T08:01:00.642Z
SHA-256 of the archived text
f342d6bd8fdcfab6f98931395bf31c7fe9e7644bd5076f5d8b7f4f7006b9a94b
Stable URL of this page
https://metraipolis.com/documento/dc_b167b9bb88ff

How to cite

Predictive value of peripheral blood immune markers for castration-resistant prostate cancer development after endocrine therapy — Europe PMC PMID:41704610 — Europe PMC (en), https://europepmc.org/article/MED/41704610 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b167b9bb88ff (Metraipolis archive dc_b167b9bb88ff, sha256 f342d6bd8fdcfab6f98931395bf31c7fe9e7644bd5076f5d8b7f4f7006b9a94b)
BibTeX
@misc{dcb167b9bb88ff,
  title = {Predictive value of peripheral blood immune markers for castration-resistant prostate cancer development after endocrine therapy — Europe PMC PMID:41704610},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41704610},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b167b9bb88ff; sha256 f342d6bd8fdcfab6f98931395bf31c7fe9e7644bd5076f5d8b7f4f7006b9a94b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704610. Agents can read the archived copy with the MCP tool read_document.